Gene expression profiling of lipoarabinomannan-treated mouse macrophage cultures infected with Mycobacterium bovis BCG

Polish Journal of Microbiology

Volumn 57, Issue 2, 2008, Pages 125-133

  Krzyzowska, Małgorzata ^a   Malewski, Tadeusz ^c   Hamasur, Beston ^b   Augustynowicz Kopeć, Ewa ^d   Schollenberger, Ada ^a   Pawłowski, Andrzej ^b   Niemiałtowski, Marek ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c MUSEUM AND INSTITUTE OF ZOOLOGY   (Poland)

^d NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Apoptosis; DNA microarray; Lipoarabinomannan; Mycobacterium bovis BCG

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYTOKINE; FAS LIGAND; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P35; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOARABINOMANNAN; PROTEIN BAX; PROTEIN BAX ALPHA; PROTEIN BCL 2; PROTEIN MCL 1; PROTEIN TNFSF2; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL ANTIGEN; CASPASE; INHIBITOR OF APOPTOSIS PROTEIN; LIPOPOLYSACCHARIDE; RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA MICROARRAY; ENZYME INHIBITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; LIPID ANALYSIS; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; TIME; UPREGULATION;

MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; APOPTOSIS; CASPASES; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION PROFILING; INHIBITOR OF APOPTOSIS PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS; UP-REGULATION;

EID: 48249099397     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Barnes P.F., D. Chatterjee, J.S. Abrams, S. Lu, E. Wang, M. Yamamura, P.J. Brennan, and R.L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J. Immunol. 149: 541-547.
2. Briken V., S.A. Porcelli, G.S. Besra and L. Kremer. 2004. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53: 391-403.
3. Cory S. and J.M. Adams. 2005. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer. Cell 8: 5-6.
4. Cory S., D.C. Huang and J.M. Adams. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-607.
5. Flynn J. L. and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
6. Flynn J.L. and J. Chan. 2003. Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr. Opin. Immunol. 15: 450-455.
7. Flynn J.L., M.M. Goldstein, J. Chan, K.J. Triebold, K. Pfeffer, C.J. Lowenstein, R. Schreiber, T.W. Mak and B.R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in nuce. Immunity 2: 561-572.
8. Hamasur B., J. Bruchfeld, M. Haile, A. Pawlowski, B. Bjorvatn, G. Kallenius, S.B. Svensson. 2001. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J. Microbiol. Methods 45: 45-52.
9. Hamasur B., M. Haile, A. Pawlowski, U. Schroder, A. Williams, G. Hatch, G. Hall, P. Marsh G. Kallenius and S.B. Svenson. 2003. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis. Vaccine 21: 4081-4093.
10. Kaminski N. and N. Friedman. 2002. Practical approaches to analyzing results of microarray experiments. Am. J. Respir. Cell. Mol. Biol. 27: 125-132.
11. Keane J., M.K. Balcewicz-Sablinska, H.G. Remold, G.L. Chupp, B.B. Meek, M.J. Fenton and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65: 298-304.
12. Klingler K., K.M. Tchou-Wong, O. Brandli, C. Aston, R. Kim, C. Chi and W.N. Rom. 1997. Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infect. Immun. 65: 5272-8.
13. Krzyzowska M., A. Pawlowski, B. Hamasur, A. Winnicka, E. Augustynowicz-Kopeć, M. Niemiałtowski. 2007. Lipoarabinomannan as a regulator of the monocyte apoptotic response to Mycobacterium bovis BCG Danish Strain 1331 Infection. Pol. J. Microbiol. 56: 89-96.
14. Krzyzowska M., A. Schollenberger, J. Skierski and M. Niemialtowski. 2002. Apoptosis during ectromelia orthopoxvirus infection is DEVDase dependent: in vitro and in vivo studies. Microbes Infect. 4: 599-611.
15. Maiti D., A. Bhattacharyya and J. Basu. 2001. Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 276: 329-333.
16. Malewski T., T. Milewicz, J. Krzysiek, E.L. Gregoraszczuk and K. Augustowska. 2005. Regulation of Msx2 gene expression by steroid hormones in human nonmalignant and malignant breast cancer explants cultured in vitro. Cancer Invest. 23: 222-228.
17. MeGarvey, J.A., D. Wagner and L.E. Bermudez. 2004. Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria. Clin. Exp. Inummol. 136: 490-500.
18. Monsarrat B., T. Brando, P. Condouret, J. Nigou and G. Puzo. 1999. Characterisation of mannooligosaccharide caps in mycobaterial lipoarabinomannan by capillary electrophoresis/clectrospray mass spectrometry. Glycobiology 9: 335-342.
19. Nigou J., M. Gilleron, T. Brando and G. Puzo. 2004. Structural analysis of mycobacterial lipoglycans. Appl Biochem Biotechnol 118: 253-267.
20. Nigou J., M. Gilleron and G. Puzo. 2003. Lipoarabinomannans: from structure to biosynthesis. Biochimie 85: 153-166.
21. Nigou J., M. Gilleron, M. Rojas, L.F́. Garcia, M. Thurnher and G. Puzo. 2002. Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response. Microbes Infect. 4: 945-53.
22. Nigou J., C. Zelle-Rieser, M. Gilleron, M. Thurnher and G. Puzo. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166: 7477-7485.
23. Perskvist N., M. Long, O. Stendahl and L. Zheng. 2002. Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. J. Immunol. 168: 6358-6365.
24. Reiner A., D. Yekutieli and Y. Benjamini. 2003. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375.
25. Roach D.R., A.G. Bean, C. Demangel, M.P. France, H. Briscoe and W.J. Britton. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168: 4620-4627.
26. Rojas M., L.F. Garcia, J. Nigou, G. Puzo and M. Olivier. 2000. Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca+2-dependent cell signaling. J. Infect. Dis. 182: 240-251.
27. Rojas M., M. Olivier, P. Gros, L.F. Barrera and L.F. Garcia. 1999. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J. Immunol. 162: 6122-6131.
28. Shen H.M. and Z.G. Liu. 2006. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 40: 928-939.
29. Sly L.M., S.M. Hingley-Wilson, N.E. Reiner and W.R. McMaster. 2003. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J. Immunol. 170: 430-437.
30. Spira A., J.D. Carroll, G. Liu, Z. Aziz, V. Shah, H. Kornfeld and J. Keane. 2003. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Am. J. Respir. Cell. Mol. Biol. 29: 545-551.
31. Strohmeier G.R. and Fenton M.J. 1999. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes Infect. 1: 709-717.
32. Tramontana J.M., U. Utaipat, A. Molloy, P. Akarosewi, M. Burroughs, S. Makonkawkeyoon, B. Johnson, J.D. Klausner, W. Rom and G. Kaplan. 1995. Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol. Med. 1: 384-397.
33. Yoshida A. and Y. Koide. 1997. Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect. Immun. 65: 1953-1955.